Ocular delivery of proteins and peptides: Challenges and novel formulation approaches

A Mandal, D Pal, V Agrahari, HM Trinh… - Advanced drug delivery …, 2018 - Elsevier
The impact of proteins and peptides on the treatment of various conditions including ocular
diseases over the past few decades has been advanced by substantial breakthroughs in …

Long-term delivery of protein therapeutics

R Vaishya, V Khurana, S Patel… - Expert opinion on drug …, 2015 - Taylor & Francis
Introduction: Proteins are effective biotherapeutics with applications in diverse ailments.
Despite being specific and potent, their full clinical potential has not yet been realized. This …

Biodegradable polymeric materials: synthetic approach

SS Panchal, DV Vasava - ACS omega, 2020 - ACS Publications
Polymeric materials obtained from petroleum resources are nonbiodegradable. Defying
degradation, they damage the environment as a result of their ending up in the landfills …

Ocular delivery of therapeutic proteins: a review

DH Shastri, AC Silva, H Almeida - Pharmaceutics, 2023 - mdpi.com
Therapeutic proteins, including monoclonal antibodies, single chain variable fragment
(ScFv), crystallizable fragment (Fc), and fragment antigen binding (Fab), have accounted for …

Delivery strategies for treatment of age-related ocular diseases: From a biological understanding to biomaterial solutions

V Delplace, S Payne, M Shoichet - Journal of Controlled Release, 2015 - Elsevier
Age-related ocular diseases, such as age-related macular degeneration (AMD), diabetic
retinopathy, and glaucoma, result in life-long functional deficits and enormous global health …

Hydrogels for sustained delivery of biologics to the back of the eye

D Chang, K Park, A Famili - Drug Discovery Today, 2019 - Elsevier
Highlights•Hydrogels provide a flexible platform for design of ocular delivery
systems.•Intraocular injection of hydrogels can be accomplished via several …

Recent perspectives on the delivery of biologics to back of the eye

M Joseph, HM Trinh, K Cholkar, D Pal… - Expert opinion on drug …, 2017 - Taylor & Francis
Introduction: Biologics are generally macromolecules, large in size with poor stability in
biological environments. Delivery of biologics to tissues at the back of the eye remains a …

Triamcinolone acetonide nanoparticles incorporated in thermoreversible gels for age-related macular degeneration

A Hirani, A Grover, YW Lee, Y Pathak… - Pharmaceutical …, 2016 - Taylor & Francis
Age-related macular degeneration (AMD) is one of the leading causes of blindness in the
US affecting millions yearly. It is characterized by intraocular neovascularization …

Composite nanoformulation therapeutics for long-term ocular delivery of macromolecules

V Agrahari, V Agrahari, WT Hung… - Molecular …, 2016 - ACS Publications
The purpose of this investigation is to design and synthesize novel pentablock (PB)
copolymer (PB-1: PCL–PLA–PEG–PLA–PCL) based nanoformulations suspended in a …

Therapeutic systems and technologies: State-of-the-art applications, opportunities, and challenges

M Almekkawy, J Chen, MD Ellis… - IEEE reviews in …, 2019 - ieeexplore.ieee.org
In this review, we present current state-of-the-art developments and challenges in the areas
of thermal therapy, ultrasound tomography, image-guided therapies, ocular drug delivery …